Produktinformation
- 2-[3-[4-(2-Pyrimidinyl)-1-piperazinyl]propyl]-1,2-benzisothiazol-3(2H)-one 1,1-Dioxide
- 2-(3-(4-(Pyrimidin-2-yl)piperazin-1-yl)propyl)benzo[d]isothiazol-3(2H)-one 1,1-Dioxide
- BAY-Vq 7813
- 1,2-Benzisothiazol-3(2H)-one, 2-(3-(4-(2-pyrimidinyl)-1-piperazinyl)propyl)-, 1,1-dioxide
- 2-(3-(4-(2-Pyrimidinyl)-1-piperazinyl)propyl)-1,2-benzisothiazolin-3-one 1,1-dioxide
- 2-[3-[4-(Pyrimidin-2-yl)piperazin-1-yl]propyl]-2,3-dihydro-1λ6,2-benzothiazole-1,1,3-trione
- 2-{3-[4-(pyrimidin-2-yl)piperazin-1-yl]propyl}-1,2-benzothiazol-3(2H)-one 1,1-dioxide
- Bay Vq 7813
- Revospirona
- Revospirona [INN-Spanish]
- Mehr Synonyme anzeigen
- Revospirone [INN:BAN]
- Revospironum
- Revospironum [INN-Latin]
- Unii-6X8764Tw2J
Applications Revospirone is a novel 5-HT1A receptor agonist that produces pharmacologically active metabolite 1-Pyrimidinylpiperazine (1-PP).
References Loscher, W., et al.: Naunyn Schmiedebergs Arch. Pharmacol., 342, 271 (1990);